Statizoid

Namibia vs Togo: Statin use vs. average non-HDL cholesterol levels

Namibia
2.8
in 2018
Togo
2.8
in 2018
Namibia rank
163rd
Togo rank
163rd

Statin use vs. average non-HDL cholesterol levels over time

  • Namibia
  • Togo
0123198019992018

How they compare

Namibia currently reports 2.8 against 2.8 in Togo, a difference of 0.

The two have swapped places 3 times across 39 shared years of data; in 1980 it was Namibia ahead.

Namibia ranks 163rd and Togo ranks 163rd of 191 countries.

Individual pages

About this data

Indicator
Statin use vs. average non-HDL cholesterol levels
Source
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
191 places, 7,449 data points, 1980–2018
Last refreshed

The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.